Development of the advanced genetic therapies for Primary Hyperoxaluria type I

Development of the advanced genetic therapies for Primary Hyperoxaluria type I

Primary Hyperoxaluria type I (PH1) is an inherited inborn error of the glyoxylate metabolism in the liver. It is caused by mutations in the AGXT gene, a gene that codes the peroxisomal enzyme alanine-glyoxylate aminotransferase (AGT). As a result of AGT deficiency oxalate, which is an end-product of...

Full description

Bibliographic Details
Main Authors: Zabaleta-Lasarte, N. (Nerea), González-Aseguinolaza, G. (Gloria), Rodriguez-Madoz, J.R. (Juan Roberto)
Format: info:eu-repo/semantics/doctoralThesis
Language:eng
Published: 2018
Subjects:
Ingeniería genética
Metabolismo humano
Materias Investigacion::Ciencias de la Salud::Genética
Online Access:https://hdl.handle.net/10171/55467

Internet

https://hdl.handle.net/10171/55467

Similar Items